⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0001662693

Clark David J

Reports to the SEC for 2 companies · LEXINGTON, MA

Transactions

9

Companies

2

Filings

7

CIK

0001662693

Forms 4 and 5

Insider transactions

9 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-02-15	TRVITrevi Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+175K sh	—	—	175,000
2022-11-14	TRVITrevi Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+300K sh	—	—	300,000
2019-09-06	ALDXAldeyra Therapeutics, Inc.P Purchase	Chief Medical Officer	PPurchase	+5,000 sh	$5.06	+$25.3K	17,878
2019-03-05	ALDXAldeyra Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+250K sh	—	—	250,000
2019-03-05	ALDXAldeyra Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+3,503 sh	—	—	11,512
2018-03-06	ALDXAldeyra Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+109K sh	—	—	108,633
2017-12-29	ALDXAldeyra Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+4,774 sh	$4.00	+$19.1K	4,774
2017-03-03	ALDXAldeyra Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+156K sh	—	—	155,656
2016-01-11	ALDXAldeyra Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+100K sh	—	—	100,000

Recent filings

7

Accepted (ET)
Feb 164
Clark David J0000950170-24-016464
SEC(opens sec.gov)
Nov 144
Clark David J0001209191-22-056635
SEC(opens sec.gov)
Sep 104
Clark David J0000899243-19-023265
SEC(opens sec.gov)
Mar 74
Clark David J0000899243-19-006730
SEC(opens sec.gov)
Mar 84
Clark David J0000899243-18-006818
SEC(opens sec.gov)
Mar 74
Aldeyra Therapeutics, Inc.0000899243-17-006713
SEC(opens sec.gov)
Jan 124
Aldeyra Therapeutics, Inc.0000899243-16-011568
SEC(opens sec.gov)

Companies

2

Address

C/O ALDEYRA THERAPEUTICS, INC. 131 HARTWELL AVENUE, SUITE 320

LEXINGTON, MA, 02421